MESNA INJECTION

MESNA INJECTION was reported 8330 times

MESNA INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE 5 0.5556
1 PLASMABLAST COUNT INCREASED 7 0.5000
2 BLADDER TELANGIECTASIA 6 0.4615
3 T-CELL LYMPHOMA REFRACTORY 11 0.3143
4 PROCTITIS BACTERIAL 5 0.3125
5 LYMPHOID TISSUE HYPOPLASIA 40 0.2614
6 THYMUS HYPOPLASIA 42 0.2414
7 PLASMA CELLS DECREASED 7 0.1400
8 AMNIOTIC FLUID INDEX DECREASED 5 0.1389
9 HUMAN BOCAVIRUS INFECTION 23 0.1217
10 RHABDOID TUMOUR 6 0.1154
11 VULVAL CELLULITIS 5 0.1000
12 VACCINE INDUCED ANTIBODY ABSENT 7 0.0875
13 SECONDARY IMMUNODEFICIENCY 97 0.0798
14 FLAGELLATE DERMATITIS 5 0.0769
15 MYCOBACTERIUM CHELONAE INFECTION 55 0.0744
16 MALASSEZIA INFECTION 5 0.0735
17 PSEUDOMONAL SEPSIS 115 0.0656
18 BK POLYOMAVIRUS TEST POSITIVE 6 0.0625
19 CYSTITIS BACTERIAL 21 0.0621
20 NOROVIRUS TEST POSITIVE 20 0.0615
21 IDIOPATHIC PNEUMONIA SYNDROME 18 0.0604
22 CYSTITIS VIRAL 23 0.0601
23 SARS-COV-2 TEST NEGATIVE 40 0.0593
24 PARAINFLUENZA VIRUS INFECTION 6 0.0583
25 ANAL INFLAMMATION 37 0.0579
26 CANCER FATIGUE 13 0.0546
27 DISSEMINATED ASPERGILLOSIS 25 0.0530
28 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III 4 0.0506
29 PERICHONDRITIS 5 0.0485
30 ENGRAFT FAILURE 13 0.0453
31 COMBINED IMMUNODEFICIENCY 7 0.0435
32 RED BLOOD CELL TRANSFUSION 16 0.0390
33 HERPES ZOSTER REACTIVATION 10 0.0382
34 TUMOUR COMPRESSION 12 0.0377
35 CYSTITIS HAEMORRHAGIC 152 0.0377
36 ENTEROBACTER BACTERAEMIA 11 0.0363
37 ABSCESS BACTERIAL 13 0.0358
38 ACUTE POLYNEUROPATHY 10 0.0350
39 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
40 CANDIDA TEST POSITIVE 12 0.0287
41 CHRONIC HEPATITIS B 9 0.0284
42 PLATELET TRANSFUSION 35 0.0272
43 FANCONI SYNDROME 37 0.0261
44 ASPERGILLUS TEST POSITIVE 8 0.0260
45 DRUG THERAPEUTIC INCOMPATIBILITY 4 0.0260
46 MANTLE CELL LYMPHOMA RECURRENT 11 0.0253
47 VENOOCCLUSIVE DISEASE 61 0.0243
48 METASTASES TO THE MEDIASTINUM 10 0.0243
49 ENGRAFTMENT SYNDROME 14 0.0237
50 PARAINFLUENZAE VIRUS INFECTION 36 0.0236
51 BETA 2 MICROGLOBULIN INCREASED 6 0.0230
52 BILE ACIDS INCREASED 4 0.0226
53 COMPLICATIONS OF BONE MARROW TRANSPLANT 8 0.0222
54 CYTOMEGALOVIRUS ANTIGEN POSITIVE 4 0.0219
55 ENTEROBACTER INFECTION 36 0.0214
56 APLASTIC ANAEMIA 110 0.0210
57 CEREBRAL TOXOPLASMOSIS 19 0.0203
58 ERYTHROPENIA 6 0.0198
59 CYTOMEGALOVIRUS HEPATITIS 7 0.0198
60 FEBRILE NEUTROPENIA 1302 0.0196
61 FUSARIUM INFECTION 13 0.0186
62 SCROTAL PAIN 10 0.0185
63 NEUROBLASTOMA 7 0.0183
64 DRUG CLEARANCE INCREASED 4 0.0179
65 APLASIA 35 0.0179
66 CYTOMEGALOVIRUS VIRAEMIA 79 0.0177
67 VIRAEMIA 23 0.0166
68 CHLOROMA 7 0.0166
69 AMNIOTIC FLUID VOLUME DECREASED 9 0.0165
70 BRONCHOPULMONARY ASPERGILLOSIS 125 0.0161
71 HUMAN HERPESVIRUS 6 INFECTION 30 0.0159
72 OSTEOSARCOMA 6 0.0156
73 CAECITIS 7 0.0156
74 BACTEROIDES INFECTION 4 0.0153
75 PERIORBITAL CELLULITIS 8 0.0149
76 VENOOCCLUSIVE LIVER DISEASE 73 0.0148
77 ANTITHROMBIN III DECREASED 4 0.0147
78 MYELOID LEUKAEMIA 7 0.0140
79 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0139
80 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 13 0.0137
81 ENTEROCOCCAL SEPSIS 11 0.0136
82 MUCOSAL INFLAMMATION 347 0.0132
83 STEM CELL TRANSPLANT 33 0.0132
84 HEPATOBILIARY DISEASE 8 0.0128
85 CHRONIC GRAFT VERSUS HOST DISEASE 46 0.0127
86 VIRAL HAEMORRHAGIC CYSTITIS 9 0.0126
87 FEBRILE BONE MARROW APLASIA 52 0.0122
88 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 4 0.0122
89 DIFFUSE ALVEOLAR DAMAGE 14 0.0122
90 PERIPHERAL MOTOR NEUROPATHY 17 0.0121
91 TOXOPLASMOSIS 13 0.0120
92 PNEUMOTHORAX SPONTANEOUS 8 0.0118
93 URINARY TRACT INFECTION STAPHYLOCOCCAL 5 0.0117
94 CORONA VIRUS INFECTION 5 0.0116
95 KLEBSIELLA BACTERAEMIA 11 0.0116
96 KLEBSIELLA SEPSIS 13 0.0115
97 NEUTROPENIC INFECTION 11 0.0115
98 PULMONARY VENO-OCCLUSIVE DISEASE 8 0.0114
99 ACUTE GRAFT VERSUS HOST DISEASE 52 0.0113
100 OTOTOXICITY 21 0.0113
101 RECTAL ABSCESS 19 0.0113
102 OVARIAN FAILURE 6 0.0112
103 RHINOVIRUS INFECTION 43 0.0110
104 BLADDER IRRITATION 7 0.0109
105 B-CELL TYPE ACUTE LEUKAEMIA 8 0.0109
106 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 30 0.0108
107 EPSTEIN-BARR VIRAEMIA 12 0.0108
108 CENTRAL LINE INFECTION 4 0.0108
109 GASTROENTERITIS NOROVIRUS 14 0.0105
110 ENCEPHALOPATHY 253 0.0103
111 HYPERTENSIVE EMERGENCY 12 0.0102
112 BONE MARROW TOXICITY 12 0.0101
113 THALAMIC INFARCTION 6 0.0101
114 MUCOSAL DISORDER 10 0.0101
115 CANDIDA SEPSIS 9 0.0100
116 ECTHYMA 4 0.0100
117 HEART TRANSPLANT 9 0.0099
118 NEUTROPENIC SEPSIS 71 0.0099
119 VENA CAVA THROMBOSIS 16 0.0096
120 B-CELL LYMPHOMA RECURRENT 5 0.0092
121 PNEUMOCOCCAL SEPSIS 6 0.0091
122 FOLLICULAR LYMPHOMA 8 0.0091
123 METAPNEUMOVIRUS INFECTION 7 0.0089
124 HEPATITIS E 14 0.0089
125 CARDIORENAL SYNDROME 5 0.0087
126 CYTOKINE RELEASE SYNDROME 174 0.0087
127 BK VIRUS INFECTION 29 0.0086
128 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 4 0.0086
129 RENAL TUBULAR DISORDER 24 0.0085
130 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
131 HAEMATOTOXICITY 81 0.0085
132 PELVIC FLUID COLLECTION 6 0.0085
133 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 12 0.0085
134 CLOSTRIDIUM DIFFICILE COLITIS 90 0.0085
135 FUNGAL SEPSIS 7 0.0084
136 BACTERIAL INFECTION 157 0.0084
137 DIAPHRAGMATIC PARALYSIS 5 0.0083
138 CYTOMEGALOVIRUS CHORIORETINITIS 16 0.0082
139 BLINDNESS CORTICAL 4 0.0082
140 RELAPSING-REMITTING MULTIPLE SCLEROSIS 7 0.0081
141 PNEUMATOSIS INTESTINALIS 23 0.0081
142 BLOOD CULTURE POSITIVE 24 0.0080
143 FANCONI SYNDROME ACQUIRED 14 0.0080
144 PROCTALGIA 51 0.0079
145 FOETAL GROWTH RESTRICTION 48 0.0079
146 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
147 NEUROTOXICITY 137 0.0078
148 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 6 0.0077
149 EROSIVE OESOPHAGITIS 13 0.0077
150 PNEUMONIA FUNGAL 30 0.0076
151 ADENOVIRUS INFECTION 22 0.0076
152 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
153 SINUSITIS FUNGAL 6 0.0075
154 CORYNEBACTERIUM INFECTION 4 0.0075
155 B-LYMPHOCYTE COUNT DECREASED 10 0.0073
156 ASPERGILLUS INFECTION 48 0.0073
157 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 6 0.0071
158 SARCOMA 8 0.0071
159 LIP HAEMORRHAGE 9 0.0071
160 FUNGAEMIA 11 0.0070
161 LEUKOENCEPHALOPATHY 26 0.0070
162 TOXIC ENCEPHALOPATHY 35 0.0069
163 ASPERGILLOSIS 9 0.0069
164 VENOUS THROMBOSIS 27 0.0069
165 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
166 PERIPHERAL SENSORY NEUROPATHY 40 0.0068
167 ESCHERICHIA BACTERAEMIA 16 0.0068
168 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 15 0.0068
169 MITRAL VALVE DISEASE 12 0.0068
170 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 40 0.0067
171 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
172 PANCYTOPENIA 372 0.0066
173 MYELODYSPLASTIC SYNDROME 95 0.0066
174 ENTEROCOLITIS INFECTIOUS 6 0.0065
175 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0065
176 GRANULOCYTE COUNT DECREASED 12 0.0065
177 STREPTOCOCCAL BACTERAEMIA 7 0.0064
178 MYOPERICARDITIS 5 0.0064
179 PNEUMONIA STREPTOCOCCAL 7 0.0064
180 CYTOPENIA 78 0.0064
181 BACILLUS INFECTION 4 0.0063
182 HYPERURICAEMIA 26 0.0063
183 HYPOPROTEINAEMIA 12 0.0063
184 HYPOALBUMINAEMIA 49 0.0063
185 CYTOMEGALOVIRUS TEST POSITIVE 11 0.0062
186 BLOOD IMMUNOGLOBULIN A DECREASED 4 0.0061
187 BACTERIAL SEPSIS 20 0.0061
188 GLOMERULONEPHRITIS 15 0.0061
189 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 16 0.0061
190 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
191 BACTERAEMIA 72 0.0061
192 CSF PROTEIN INCREASED 5 0.0060
193 DIFFUSE LARGE B-CELL LYMPHOMA 46 0.0060
194 THROMBOTIC MICROANGIOPATHY 57 0.0058
195 DYSPLASIA 7 0.0058
196 HYPOPHOSPHATAEMIA 43 0.0058
197 CENTRAL NERVOUS SYSTEM LYMPHOMA 8 0.0058
198 RENAL TUBULAR INJURY 7 0.0058
199 KLEBSIELLA INFECTION 29 0.0057
200 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
201 CEREBRAL ARTERY OCCLUSION 6 0.0056
202 GRAFT VERSUS HOST DISEASE 40 0.0056
203 CARDIOTOXICITY 49 0.0055
204 TUMOUR LYSIS SYNDROME 48 0.0055
205 GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0054
206 ENTERITIS 34 0.0053
207 TRANSPLANT FAILURE 13 0.0053
208 PULPITIS DENTAL 5 0.0053
209 SECOND PRIMARY MALIGNANCY 44 0.0053
210 OESOPHAGEAL CANDIDIASIS 21 0.0053
211 STAPHYLOCOCCAL SEPSIS 26 0.0053
212 CONTINUOUS HAEMODIAFILTRATION 5 0.0051
213 STREPTOCOCCAL SEPSIS 6 0.0051
214 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 13 0.0050
215 VOCAL CORD PARALYSIS 9 0.0050
216 MYELOSUPPRESSION 180 0.0050
217 HYPOGONADISM 5 0.0049
218 CHRONIC HEPATITIS 4 0.0049
219 CATHETER RELATED INFECTION 5 0.0049
220 ANAEMIA HAEMOLYTIC AUTOIMMUNE 4 0.0048
221 FIBRIN D DIMER INCREASED 17 0.0048
222 NEUTROPHIL COUNT DECREASED 194 0.0048
223 GASTROINTESTINAL TOXICITY 22 0.0046
224 NEPHROPATHY TOXIC 51 0.0045
225 CYTOMEGALOVIRUS INFECTION REACTIVATION 20 0.0045
226 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8 0.0045
227 DRUG LEVEL FLUCTUATING 4 0.0045
228 JUGULAR VEIN THROMBOSIS 8 0.0045
229 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
230 GLYCOSURIA 6 0.0044
231 STENOTROPHOMONAS INFECTION 6 0.0044
232 INTRA-UTERINE DEATH 7 0.0044
233 PNEUMONIA KLEBSIELLA 8 0.0043
234 LEUKOPENIA 215 0.0043
235 FEBRILE INFECTION 5 0.0042
236 NEUTROPENIA 577 0.0042
237 HYPERPHOSPHATAEMIA 9 0.0042
238 ENTEROCOCCAL INFECTION 20 0.0041
239 RENAL TUBULAR ACIDOSIS 9 0.0041
240 HYPOGAMMAGLOBULINAEMIA 27 0.0041
241 BONE MARROW DEPRESSION 4 0.0041
242 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
243 LYMPHOPENIA 57 0.0040
244 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 38 0.0040
245 HYPERBILIRUBINAEMIA 41 0.0040
246 SEPTIC SHOCK 172 0.0039
247 BONE MARROW FAILURE 80 0.0039
248 GLUCOSE URINE PRESENT 5 0.0039
249 OSTEOLYSIS 8 0.0039
250 CYTOMEGALOVIRUS INFECTION 65 0.0039
251 SLOW RESPONSE TO STIMULI 5 0.0039
252 NEOPLASM RECURRENCE 13 0.0038
253 DRUG CLEARANCE DECREASED 5 0.0038
254 SMALL FOR DATES BABY 19 0.0038
255 NON-HODGKIN'S LYMPHOMA 5 0.0038
256 PACKED RED BLOOD CELL TRANSFUSION 5 0.0038
257 ENTEROCOCCAL BACTERAEMIA 4 0.0038
258 ASTERIXIS 4 0.0038
259 POLYNEUROPATHY 45 0.0038
260 PULMONARY HAEMORRHAGE 29 0.0037
261 GRANULOCYTOPENIA 21 0.0037
262 LYMPHOCYTE COUNT DECREASED 65 0.0037
263 PULMONARY TOXICITY 26 0.0037
264 OESOPHAGITIS 40 0.0037
265 HEPATITIS B 22 0.0036
266 LOW BIRTH WEIGHT BABY 29 0.0036
267 ENCEPHALITIS 25 0.0036
268 TACHYARRHYTHMIA 9 0.0036
269 VIRAL INFECTION 120 0.0036
270 SYSTEMIC CANDIDA 9 0.0036
271 THROMBOCYTOPENIA 399 0.0036
272 HEPATORENAL SYNDROME 6 0.0036
273 ACUTE LYMPHOCYTIC LEUKAEMIA 10 0.0035
274 HYPOKALAEMIA 163 0.0035
275 SKIN WOUND 6 0.0035
276 NOCARDIOSIS 9 0.0035
277 BLOOD FIBRINOGEN DECREASED 4 0.0035
278 NON-CARDIAC CHEST PAIN 11 0.0035
279 HAEMOLYTIC URAEMIC SYNDROME 8 0.0034
280 ALOPECIA AREATA 6 0.0034
281 MULTI-ORGAN FAILURE 59 0.0034
282 HYPERNATRAEMIA 17 0.0034
283 NORMOCYTIC ANAEMIA 5 0.0034
284 ACUTE RESPIRATORY DISTRESS SYNDROME 60 0.0034
285 PULMONARY ALVEOLAR HAEMORRHAGE 19 0.0034
286 CAPILLARY LEAK SYNDROME 7 0.0034
287 DEAFNESS NEUROSENSORY 11 0.0033
288 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 17 0.0033
289 METABOLIC ENCEPHALOPATHY 10 0.0033
290 CARDIAC FAILURE ACUTE 22 0.0033
291 ACCIDENT 39 0.0033
292 SEPSIS 363 0.0033
293 ORAL MUCOSAL ERUPTION 5 0.0033
294 CLOSTRIDIAL INFECTION 11 0.0032
295 PORTAL HYPERTENSION 10 0.0032
296 B-CELL LYMPHOMA 11 0.0032
297 AGRANULOCYTOSIS 60 0.0032
298 MONOPLEGIA 14 0.0032
299 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 24 0.0032
300 CLOSTRIDIUM TEST POSITIVE 7 0.0032
301 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
302 TRANSFUSION 33 0.0031
303 BLOOD BILIRUBIN ABNORMAL 4 0.0031
304 THROMBOTIC THROMBOCYTOPENIC PURPURA 11 0.0031
305 FACIAL PARESIS 11 0.0031
306 MULTIPLE ORGAN DYSFUNCTION SYNDROME 88 0.0031
307 ESCHERICHIA SEPSIS 9 0.0031
308 STRONGYLOIDIASIS 5 0.0031
309 VENTRICULAR DYSFUNCTION 8 0.0031
310 ACUTE MYELOID LEUKAEMIA 48 0.0031
311 HAEMORRHOIDS 60 0.0031
312 COVID-19 PNEUMONIA 36 0.0030
313 EPSTEIN-BARR VIRUS INFECTION 19 0.0030
314 ORAL CANDIDIASIS 40 0.0030
315 SEBORRHOEIC DERMATITIS 5 0.0030
316 CYTOLYTIC HEPATITIS 10 0.0030
317 NORMOCHROMIC NORMOCYTIC ANAEMIA 9 0.0030
318 DEVICE RELATED INFECTION 46 0.0030
319 URINARY TRACT OBSTRUCTION 7 0.0029
320 DRUG TOXICITY 40 0.0029
321 INTRACARDIAC THROMBUS 9 0.0029
322 GASTROINTESTINAL OBSTRUCTION 7 0.0029
323 DIABETES INSIPIDUS 7 0.0029
324 HYPOCALCAEMIA 55 0.0029
325 MENINGITIS ASEPTIC 13 0.0029
326 BLOOD DISORDER 23 0.0029
327 ACUTE PULMONARY OEDEMA 16 0.0028
328 FUNGAL INFECTION 95 0.0028
329 HYPERVOLAEMIA 14 0.0028
330 TACHYPNOEA 38 0.0028
331 HAEMOLYTIC ANAEMIA 25 0.0028
332 HAEMATURIA 95 0.0028
333 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
334 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
335 HERPES SIMPLEX 17 0.0026
336 LEFT VENTRICULAR FAILURE 9 0.0026
337 LUNG INFILTRATION 23 0.0026
338 BLOOD CREATININE ABNORMAL 9 0.0026
339 PSEUDOMONAS INFECTION 22 0.0026
340 BODY TEMPERATURE INCREASED 52 0.0025
341 OCCULT BLOOD POSITIVE 5 0.0025
342 CARDIAC TAMPONADE 12 0.0025
343 LUNG CONSOLIDATION 7 0.0025
344 HAEMODIALYSIS 21 0.0025
345 CANDIDIASIS 10 0.0025
346 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
347 TUMOUR HAEMORRHAGE 7 0.0025
348 RESPIRATORY DISTRESS 67 0.0024
349 CHRONIC SINUSITIS 9 0.0024
350 PETECHIAE 25 0.0024
351 DISEASE PROGRESSION 283 0.0024
352 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
353 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
354 SINUS TACHYCARDIA 33 0.0023
355 EJECTION FRACTION DECREASED 36 0.0023
356 HYPOVOLAEMIC SHOCK 11 0.0023
357 CERVICAL DYSPLASIA 5 0.0023
358 CATATONIA 12 0.0023
359 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
360 PNEUMOTHORAX 36 0.0023
361 DIASTOLIC DYSFUNCTION 7 0.0023
362 STOMATITIS 137 0.0023
363 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
364 SPINAL COLUMN INJURY 5 0.0022
365 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
366 MENTAL STATUS CHANGES 62 0.0022
367 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
368 HYPOXIA 78 0.0022
369 HEPATITIS B REACTIVATION 7 0.0022
370 TRANSAMINASES INCREASED 49 0.0022
371 METASTASES TO MENINGES 5 0.0022
372 FOLLICULITIS 23 0.0022
373 ESCHERICHIA INFECTION 18 0.0022
374 ODYNOPHAGIA 13 0.0022
375 ATELECTASIS 21 0.0022
376 METASTASES TO CENTRAL NERVOUS SYSTEM 28 0.0022
377 CONGESTIVE CARDIOMYOPATHY 9 0.0022
378 PLATELET COUNT DECREASED 230 0.0022
379 HEPATOTOXICITY 48 0.0022
380 BILIRUBIN CONJUGATED INCREASED 5 0.0021
381 CACHEXIA 11 0.0021
382 NEUTROPHIL COUNT ABNORMAL 6 0.0021
383 HEPATOCELLULAR INJURY 30 0.0021
384 METASTASIS 15 0.0021
385 ANAEMIA 400 0.0021
386 PLEURAL EFFUSION 126 0.0021
387 HYPERTRIGLYCERIDAEMIA 12 0.0020
388 EMBOLISM 17 0.0020
389 MOUTH HAEMORRHAGE 15 0.0020
390 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 21 0.0020
391 LYMPHOPROLIFERATIVE DISORDER 6 0.0020
392 HEPATOMEGALY 20 0.0020
393 THORACIC VERTEBRAL FRACTURE 6 0.0020
394 PYREXIA 701 0.0020
395 HISTIOCYTOSIS HAEMATOPHAGIC 6 0.0020
396 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
397 BLOOD BILIRUBIN INCREASED 54 0.0020
398 URINARY TRACT INFECTION BACTERIAL 5 0.0020
399 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
400 WHITE BLOOD CELL COUNT DECREASED 214 0.0020
401 MALNUTRITION 22 0.0020
402 CORONAVIRUS INFECTION 13 0.0020
403 CELLULITIS 98 0.0019
404 CEREBRAL ISCHAEMIA 10 0.0019
405 RADICULOPATHY 5 0.0019
406 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
407 CARDIOMYOPATHY 28 0.0019
408 HYPOVOLAEMIA 11 0.0019
409 METASTASES TO LIVER 33 0.0019
410 VENTRICULAR HYPOKINESIA 6 0.0019
411 ABDOMINAL MASS 5 0.0019
412 PERICARDIAL EFFUSION 43 0.0019
413 C-REACTIVE PROTEIN INCREASED 66 0.0018
414 PURPURA 16 0.0018
415 ELECTROLYTE IMBALANCE 21 0.0018
416 BLOOD CREATINE INCREASED 8 0.0018
417 OLIGOHYDRAMNIOS 6 0.0018
418 RENAL FAILURE ACUTE 74 0.0017
419 HYPOMAGNESAEMIA 24 0.0017
420 METASTASES TO BONE 28 0.0017
421 COLITIS 63 0.0017
422 STILLBIRTH 8 0.0017
423 BONE MARROW DISORDER 5 0.0017
424 GUILLAIN-BARRE SYNDROME 8 0.0017
425 VARICES OESOPHAGEAL 5 0.0017
426 FLUID OVERLOAD 24 0.0016
427 EMBOLISM VENOUS 5 0.0016
428 PNEUMONIA BACTERIAL 15 0.0016
429 RENAL TUBULAR NECROSIS 16 0.0016
430 ATRIAL FLUTTER 13 0.0016
431 ORGANISING PNEUMONIA 8 0.0016
432 DELIRIUM 56 0.0016
433 OLIGURIA 10 0.0016
434 ILEUS 20 0.0016
435 URINE OUTPUT DECREASED 14 0.0016
436 HEMIPARESIS 27 0.0016
437 MITRAL VALVE INCOMPETENCE 18 0.0016
438 CATHETER SITE INFECTION 6 0.0016
439 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
440 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
441 PREMATURE DELIVERY 25 0.0016
442 PNEUMONIA VIRAL 5 0.0016
443 ALANINE AMINOTRANSFERASE INCREASED 96 0.0016
444 HAEMOLYSIS 12 0.0016
445 LYMPHADENOPATHY 55 0.0016
446 PAPILLOEDEMA 7 0.0015
447 PORTAL VEIN THROMBOSIS 5 0.0015
448 HYPERGLYCAEMIA 56 0.0015
449 PULMONARY HYPERTENSION 32 0.0015
450 PNEUMONITIS 41 0.0015
451 THERAPY NON-RESPONDER 67 0.0015
452 GAMMA-GLUTAMYLTRANSFERASE INCREASED 33 0.0015
453 ADRENAL INSUFFICIENCY 18 0.0015
454 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
455 HYDRONEPHROSIS 11 0.0015
456 NEUTROPHIL COUNT INCREASED 15 0.0015
457 ECCHYMOSIS 10 0.0015
458 WOUND COMPLICATION 5 0.0015
459 STAPHYLOCOCCAL INFECTION 48 0.0015
460 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
461 RESPIRATORY FAILURE 106 0.0015
462 SINUS BRADYCARDIA 14 0.0014
463 TACHYCARDIA 128 0.0014
464 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
465 ANGIOPATHY 8 0.0014
466 TYPE I HYPERSENSITIVITY 5 0.0014
467 HYPERPYREXIA 6 0.0014
468 STATUS EPILEPTICUS 16 0.0014
469 MYOCARDIAL ISCHAEMIA 16 0.0014
470 INFECTION 203 0.0014
471 HYPONATRAEMIA 79 0.0014
472 ORAL HERPES 27 0.0014
473 COAGULOPATHY 23 0.0014
474 BRADYPHRENIA 9 0.0014
475 ASPARTATE AMINOTRANSFERASE INCREASED 73 0.0014
476 DIVERTICULUM INTESTINAL 6 0.0014
477 PETIT MAL EPILEPSY 7 0.0014
478 GROIN PAIN 12 0.0014
479 THROMBOCYTOSIS 5 0.0014
480 ACUTE KIDNEY INJURY 208 0.0014
481 AMYLASE INCREASED 5 0.0014
482 THERAPY PARTIAL RESPONDER 21 0.0013
483 TONSILLITIS 7 0.0013
484 HICCUPS 11 0.0013
485 SUSPECTED OFF LABEL USE 6 0.0013
486 POLYARTHRITIS 7 0.0013
487 LEUKOCYTOSIS 24 0.0013
488 CHEMOTHERAPY 5 0.0013
489 NYSTAGMUS 7 0.0013
490 HAEMODYNAMIC INSTABILITY 10 0.0013
491 HYPERTHERMIA 10 0.0013
492 ACIDOSIS 10 0.0013
493 COMMUNICATION DISORDER 5 0.0013
494 CANDIDA INFECTION 22 0.0013
495 LOCALISED OEDEMA 6 0.0013
496 TOXIC SKIN ERUPTION 13 0.0013
497 CYSTITIS 41 0.0013
498 BLOOD BLISTER 4 0.0013
499 ANURIA 11 0.0013
500 HAEMOGLOBIN DECREASED 131 0.0013
501 PULMONARY MASS 19 0.0013
502 HAEMATEMESIS 32 0.0013
503 STREPTOCOCCAL INFECTION 7 0.0013
504 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
505 VENTRICULAR EXTRASYSTOLES 13 0.0013
506 HYPOPHAGIA 32 0.0013
507 CUSHINGOID 4 0.0012
508 APHASIA 37 0.0012
509 LUNG INFECTION 19 0.0012
510 ABNORMAL FAECES 10 0.0012
511 CARDIOMEGALY 15 0.0012
512 ANAPHYLACTOID REACTION 5 0.0012
513 METABOLIC DISORDER 7 0.0012
514 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
515 DERMATITIS EXFOLIATIVE 6 0.0012
516 HEPATIC FAILURE 36 0.0012
517 NERVE COMPRESSION 11 0.0012
518 GRAND MAL CONVULSION 11 0.0012
519 UPPER RESPIRATORY TRACT INFECTION 55 0.0012
520 HALLUCINATIONS, MIXED 5 0.0012
521 BRAIN OEDEMA 15 0.0012
522 WOUND INFECTION 13 0.0012
523 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
524 PHLEBITIS 6 0.0012
525 ASCITES 34 0.0012
526 HYPOTENSION 232 0.0012
527 FAILURE TO THRIVE 6 0.0012
528 HEPATIC FUNCTION ABNORMAL 43 0.0012
529 HYPERTRANSAMINASAEMIA 8 0.0011
530 TENSION 7 0.0011
531 BLOOD ALBUMIN DECREASED 9 0.0011
532 NEUROPATHY PERIPHERAL 107 0.0011
533 GASTRITIS 29 0.0011
534 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
535 GASTROENTERITIS 16 0.0011
536 PREMATURE BABY 33 0.0011
537 ASPIRATION 12 0.0011
538 BLOOD PHOSPHORUS DECREASED 4 0.0011
539 STEVENS-JOHNSON SYNDROME 24 0.0011
540 SKIN TOXICITY 6 0.0011
541 SMALL INTESTINAL OBSTRUCTION 13 0.0011
542 HYPERKALAEMIA 37 0.0011
543 PULSE ABSENT 5 0.0011
544 ENTEROCOLITIS 6 0.0010
545 BLOOD URIC ACID INCREASED 6 0.0010
546 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
547 CAESAREAN SECTION 12 0.0010
548 CARDIOPULMONARY FAILURE 4 0.0010
549 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
550 HEPATIC CYTOLYSIS 13 0.0010
551 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
552 RESPIRATORY RATE INCREASED 9 0.0010
553 HAIR GROWTH ABNORMAL 7 0.0010
554 GENERAL PHYSICAL HEALTH DETERIORATION 117 0.0010
555 FACE OEDEMA 17 0.0010
556 TRICUSPID VALVE INCOMPETENCE 8 0.0010
557 MALIGNANT NEOPLASM PROGRESSION 103 0.0010
558 ANAL INCONTINENCE 9 0.0010
559 SHOCK 23 0.0010
560 PLATELET COUNT ABNORMAL 6 0.0010
561 CHILLS 116 0.0010
562 EPISTAXIS 74 0.0010
563 RASH MACULO-PAPULAR 22 0.0010
564 HYPOTHERMIA 10 0.0010
565 BRONCHOSPASM 14 0.0010
566 POLYURIA 8 0.0010
567 GENERALISED OEDEMA 12 0.0010
568 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
569 APPENDICITIS 9 0.0010
570 PERIORBITAL OEDEMA 5 0.0010
571 MYOCARDITIS 11 0.0010
572 DISORIENTATION 38 0.0010
573 MEDICAL DEVICE COMPLICATION 7 0.0009
574 AORTIC VALVE INCOMPETENCE 4 0.0009
575 ABSCESS LIMB 4 0.0009
576 FACIAL PARALYSIS 8 0.0009
577 SKIN HYPERPIGMENTATION 8 0.0009
578 LIVER FUNCTION TEST ABNORMAL 27 0.0009
579 INCOHERENT 6 0.0009
580 CONFUSIONAL STATE 149 0.0009
581 BLOOD CREATININE INCREASED 60 0.0009
582 HYDROCEPHALUS 5 0.0009
583 POLYP 6 0.0009
584 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
585 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
586 RENAL FAILURE CHRONIC 7 0.0009
587 CARDIAC ARREST 75 0.0009
588 HYPERKERATOSIS 5 0.0009
589 LYMPHOMA 14 0.0009
590 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
591 HEPATITIS 23 0.0009
592 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
593 PNEUMONIA 289 0.0009
594 INTESTINAL PERFORATION 10 0.0009
595 CARDIO-RESPIRATORY ARREST 37 0.0009
596 PNEUMONIA ASPIRATION 22 0.0009
597 HERPES VIRUS INFECTION 5 0.0009
598 LYMPHOEDEMA 6 0.0009
599 UROSEPSIS 8 0.0009
600 NERVOUS SYSTEM DISORDER 27 0.0009
601 COMA 41 0.0009
602 TOXICITY TO VARIOUS AGENTS 145 0.0009
603 SHOCK HAEMORRHAGIC 7 0.0009
604 DECUBITUS ULCER 7 0.0009
605 ERYTHEMA MULTIFORME 8 0.0009
606 RIGHT VENTRICULAR FAILURE 6 0.0009
607 DUODENAL ULCER 6 0.0008
608 PRODUCT USE IN UNAPPROVED INDICATION 210 0.0008
609 ACUTE CORONARY SYNDROME 7 0.0008
610 METABOLIC ACIDOSIS 27 0.0008
611 ATAXIA 10 0.0008
612 ATRIAL FIBRILLATION 82 0.0008
613 DEAFNESS 22 0.0008
614 RENAL FAILURE 111 0.0008
615 PULMONARY CONGESTION 11 0.0008
616 ACUTE RESPIRATORY FAILURE 16 0.0008
617 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
618 CYANOSIS 13 0.0008
619 ORAL DISORDER 6 0.0008
620 VOMITING 384 0.0008
621 BREATH SOUNDS ABNORMAL 4 0.0008
622 RED BLOOD CELL COUNT DECREASED 23 0.0008
623 PANCREATITIS ACUTE 18 0.0008
624 SPINAL OSTEOARTHRITIS 7 0.0008
625 OSTEONECROSIS 26 0.0008
626 DRUG INTERACTION 125 0.0008
627 SUBARACHNOID HAEMORRHAGE 8 0.0008
628 GASTROINTESTINAL INFECTION 7 0.0008
629 METASTASES TO LUNG 9 0.0008
630 DRUG RESISTANCE 20 0.0008
631 HAEMOGLOBIN ABNORMAL 5 0.0008
632 NEOPLASM PROGRESSION 27 0.0008
633 URINARY INCONTINENCE 23 0.0008
634 RESPIRATORY TRACT INFECTION 20 0.0008
635 DERMATITIS 16 0.0008
636 MYOCLONUS 9 0.0008
637 CONVULSION 43 0.0008
638 CHOLECYSTITIS CHRONIC 5 0.0007
639 ANAL FISSURE 4 0.0007
640 OFF LABEL USE 653 0.0007
641 COLITIS ISCHAEMIC 5 0.0007
642 PULMONARY OEDEMA 33 0.0007
643 PROTEINURIA 14 0.0007
644 UNRESPONSIVE TO STIMULI 19 0.0007
645 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
646 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
647 DEEP VEIN THROMBOSIS 47 0.0007
648 RASH PAPULAR 16 0.0007
649 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
650 SKIN INFECTION 8 0.0007
651 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
652 DYSURIA 26 0.0007
653 DIVERTICULUM 5 0.0007
654 FULL BLOOD COUNT DECREASED 14 0.0007
655 OXYGEN SATURATION DECREASED 39 0.0007
656 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
657 DERMATITIS BULLOUS 5 0.0007
658 FEEDING DISORDER 14 0.0007
659 DYSKINESIA 28 0.0007
660 VASCULITIS 8 0.0007
661 DEHYDRATION 91 0.0007
662 IMMUNOSUPPRESSION 6 0.0007
663 DRUG EXPOSURE DURING PREGNANCY 23 0.0007
664 DISEASE RECURRENCE 32 0.0007
665 CHOLECYSTITIS 8 0.0007
666 IMMUNODEFICIENCY 10 0.0007
667 SUNBURN 5 0.0007
668 ORAL PAIN 15 0.0007
669 HAEMORRHAGE INTRACRANIAL 10 0.0007
670 ACUTE HEPATIC FAILURE 9 0.0007
671 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
672 DIPLOPIA 17 0.0007
673 LIPASE INCREASED 5 0.0007
674 PULMONARY EMBOLISM 62 0.0007
675 INFUSION RELATED REACTION 43 0.0006
676 HYPERCALCAEMIA 8 0.0006
677 SKIN LACERATION 7 0.0006
678 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
679 PANCREATITIS 34 0.0006
680 APNOEA 5 0.0006
681 DIARRHOEA HAEMORRHAGIC 6 0.0006
682 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
683 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
684 DIALYSIS 9 0.0006
685 RHINITIS 5 0.0006
686 HYPERTENSION 129 0.0006
687 OEDEMA 33 0.0006
688 RENAL IMPAIRMENT 51 0.0006
689 BRADYCARDIA 32 0.0006
690 MADAROSIS 7 0.0006
691 SPLENOMEGALY 7 0.0006
692 BRONCHIECTASIS 4 0.0006
693 HERPES ZOSTER 34 0.0006
694 CIRCULATORY COLLAPSE 10 0.0006
695 HEPATIC CIRRHOSIS 11 0.0006
696 HALLUCINATION 44 0.0006
697 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
698 PYELONEPHRITIS 5 0.0006
699 ABDOMINAL PAIN 131 0.0006
700 FACIAL PAIN 5 0.0006
701 CEREBRAL HAEMORRHAGE 20 0.0006
702 MYDRIASIS 7 0.0005
703 PRODUCT ADMINISTRATION ERROR 11 0.0005
704 DECREASED APPETITE 126 0.0005
705 RHINORRHOEA 35 0.0005
706 FOETAL EXPOSURE DURING PREGNANCY 44 0.0005
707 URINARY RETENTION 18 0.0005
708 PLATELET COUNT INCREASED 7 0.0005
709 CARDIAC FAILURE 43 0.0005
710 DIARRHOEA 345 0.0005
711 FLANK PAIN 5 0.0005
712 PERITONITIS 11 0.0005
713 LEUKAEMIA 5 0.0005
714 MOUTH ULCERATION 11 0.0005
715 LETHARGY 30 0.0005
716 SEROTONIN SYNDROME 10 0.0005
717 JAUNDICE 14 0.0005
718 AFFECT LABILITY 5 0.0005
719 LIVER DISORDER 23 0.0005
720 EOSINOPHILIA 9 0.0005
721 COLD SWEAT 9 0.0005
722 HAEMATOCRIT DECREASED 10 0.0005
723 ISCHAEMIC STROKE 9 0.0005
724 AGITATION 37 0.0005
725 GASTROENTERITIS VIRAL 9 0.0005
726 OSTEOMYELITIS 9 0.0005
727 NO THERAPEUTIC RESPONSE 6 0.0005
728 TOOTH ABSCESS 5 0.0005
729 MOTOR DYSFUNCTION 5 0.0005
730 SUBDURAL HAEMATOMA 7 0.0005
731 CARDIOGENIC SHOCK 7 0.0005
732 SKIN DISORDER 16 0.0005
733 DYSARTHRIA 18 0.0005
734 BLOOD SODIUM DECREASED 9 0.0005
735 PERICARDITIS 8 0.0005
736 OEDEMA PERIPHERAL 58 0.0005
737 INTERSTITIAL LUNG DISEASE 23 0.0005
738 INCONTINENCE 5 0.0005
739 SUDDEN DEATH 5 0.0005
740 CONSTIPATION 103 0.0005
741 NAUSEA 373 0.0005
742 CHOLESTASIS 9 0.0005
743 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
744 BLOOD POTASSIUM DECREASED 14 0.0005
745 ANAPHYLACTIC SHOCK 12 0.0005
746 HYPOAESTHESIA ORAL 7 0.0005
747 BLOOD MAGNESIUM DECREASED 4 0.0005
748 ORTHOSTATIC HYPOTENSION 8 0.0005
749 DENTAL CARIES 5 0.0005
750 URINARY TRACT INFECTION 77 0.0005
751 SYNCOPE 45 0.0004
752 COGNITIVE DISORDER 21 0.0004
753 BACK PAIN 104 0.0004
754 DRUG-INDUCED LIVER INJURY 14 0.0004
755 INFLAMMATION 23 0.0004
756 DYSPHAGIA 42 0.0004
757 PALLOR 12 0.0004
758 ULCER 7 0.0004
759 GINGIVAL BLEEDING 6 0.0004
760 ABSCESS 7 0.0004
761 MICTURITION URGENCY 5 0.0004
762 NEOPLASM 5 0.0004
763 RESPIRATORY DISORDER 13 0.0004
764 CONJUNCTIVITIS 8 0.0004
765 EYELID OEDEMA 5 0.0004
766 PARALYSIS 6 0.0004
767 HYPERLIPIDAEMIA 5 0.0004
768 RASH ERYTHEMATOUS 20 0.0004
769 BLOOD UREA INCREASED 7 0.0004
770 NOCTURIA 5 0.0004
771 METRORRHAGIA 7 0.0004
772 PLASMA CELL MYELOMA 16 0.0004
773 RESPIRATORY DEPRESSION 5 0.0004
774 PRODUCT USE ISSUE 76 0.0004
775 PHARYNGITIS 5 0.0004
776 ARRHYTHMIA 19 0.0004
777 DYSPNOEA EXERTIONAL 15 0.0004
778 SEIZURE 46 0.0004
779 DIVERTICULITIS 11 0.0004
780 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
781 EPILEPSY 12 0.0004
782 ANOREXIA 5 0.0004
783 BONE DISORDER 7 0.0004
784 HEPATIC ENZYME INCREASED 26 0.0004
785 ANAPHYLACTIC REACTION 21 0.0004
786 HALLUCINATION, VISUAL 8 0.0004
787 HEPATIC STEATOSIS 7 0.0004
788 TREATMENT FAILURE 31 0.0004
789 RENAL INJURY 11 0.0004
790 PRESYNCOPE 9 0.0004
791 BLOOD URINE PRESENT 7 0.0004
792 LUNG DISORDER 18 0.0004
793 PRODUCT PRESCRIBING ISSUE 8 0.0004
794 LIVER INJURY 9 0.0004
795 RENAL DISORDER 17 0.0004
796 PERIPHERAL COLDNESS 5 0.0004
797 VENTRICULAR TACHYCARDIA 6 0.0004
798 SPEECH DISORDER 19 0.0004
799 BONE PAIN 21 0.0004
800 COORDINATION ABNORMAL 5 0.0004
801 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
802 PAIN IN JAW 10 0.0004
803 SPINAL FRACTURE 7 0.0003
804 HEAD INJURY 11 0.0003
805 MUSCLE TWITCHING 8 0.0003
806 THERAPEUTIC RESPONSE DECREASED 21 0.0003
807 ALOPECIA 68 0.0003
808 DRUG ERUPTION 6 0.0003
809 TREMOR 56 0.0003
810 POLLAKIURIA 14 0.0003
811 SYNOVITIS 6 0.0003
812 BLOOD PRESSURE DECREASED 22 0.0003
813 PELVIC PAIN 6 0.0003
814 ABNORMAL BEHAVIOUR 13 0.0003
815 MUSCULAR WEAKNESS 37 0.0003
816 HAEMORRHAGE 34 0.0003
817 FAECES DISCOLOURED 7 0.0003
818 DELUSION 5 0.0003
819 MELAENA 7 0.0003
820 DERMATITIS ALLERGIC 4 0.0003
821 FLUID RETENTION 16 0.0003
822 PRODUCTIVE COUGH 15 0.0003
823 ILL-DEFINED DISORDER 19 0.0003
824 GASTROINTESTINAL DISORDER 28 0.0003
825 CHEST DISCOMFORT 32 0.0003
826 DYSTONIA 6 0.0003
827 HAEMATOMA 8 0.0003
828 ASTHENIA 115 0.0003
829 DYSPNOEA 173 0.0003
830 CHOLELITHIASIS 10 0.0003
831 CHRONIC KIDNEY DISEASE 23 0.0003
832 MYALGIA 51 0.0003
833 THROMBOSIS 24 0.0003
834 DEATH 255 0.0003
835 ANGIOEDEMA 13 0.0003
836 SOMNOLENCE 59 0.0003
837 SCAR 5 0.0003
838 LOCAL SWELLING 5 0.0003
839 IRRITABILITY 17 0.0003
840 COUGH 78 0.0003
841 SWELLING FACE 18 0.0003
842 TOOTHACHE 5 0.0003
843 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
844 END STAGE RENAL DISEASE 5 0.0003
845 CARDIAC FAILURE CONGESTIVE 22 0.0003
846 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
847 WEIGHT DECREASED 76 0.0003
848 SKIN ULCER 7 0.0003
849 OROPHARYNGEAL PAIN 25 0.0003
850 LACRIMATION INCREASED 8 0.0003
851 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
852 EXPOSURE DURING PREGNANCY 16 0.0003
853 BASAL CELL CARCINOMA 4 0.0003
854 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
855 WHEEZING 15 0.0003
856 HAEMOPTYSIS 7 0.0003
857 PREGNANCY 5 0.0002
858 SKIN EXFOLIATION 21 0.0002
859 DRUG INTOLERANCE 24 0.0002
860 FATIGUE 193 0.0002
861 LACTIC ACIDOSIS 8 0.0002
862 RESTLESSNESS 9 0.0002
863 PAIN 151 0.0002
864 IMPAIRED HEALING 8 0.0002
865 DRUG LEVEL INCREASED 4 0.0002
866 EXTRAPYRAMIDAL DISORDER 6 0.0002
867 TINNITUS 11 0.0002
868 HEADACHE 150 0.0002
869 CHEST PAIN 44 0.0002
870 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
871 CARDIOVASCULAR DISORDER 6 0.0002
872 OSTEOARTHRITIS 10 0.0002
873 CARDIAC DISORDER 22 0.0002
874 RASH 102 0.0002
875 MENTAL DISORDER 10 0.0002
876 HYPOGLYCAEMIA 11 0.0002
877 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
878 NEOPLASM MALIGNANT 15 0.0002
879 ERYTHEMA 46 0.0002
880 UNDERDOSE 16 0.0002
881 OSTEOPOROSIS 9 0.0002
882 SINUSITIS 22 0.0002
883 WOUND 6 0.0002
884 HYPOAESTHESIA 32 0.0002
885 VERTIGO 13 0.0002
886 HYPERHIDROSIS 27 0.0002
887 VAGINAL HAEMORRHAGE 9 0.0002
888 NEURALGIA 5 0.0002
889 PAIN IN EXTREMITY 60 0.0002
890 ACUTE MYOCARDIAL INFARCTION 6 0.0002
891 DISABILITY 4 0.0002
892 OSTEONECROSIS OF JAW 5 0.0002
893 MALAISE 88 0.0002
894 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
895 ABDOMINAL DISTENSION 20 0.0002
896 MUSCULOSKELETAL PAIN 10 0.0002
897 PARAESTHESIA 30 0.0002
898 EATING DISORDER 4 0.0002
899 LOSS OF CONSCIOUSNESS 24 0.0002
900 MOVEMENT DISORDER 6 0.0002
901 RECTAL HAEMORRHAGE 8 0.0002
902 NIGHT SWEATS 6 0.0002
903 BALANCE DISORDER 16 0.0002
904 RASH PRURITIC 10 0.0002
905 SKIN LESION 5 0.0002
906 HAEMATOCHEZIA 10 0.0002
907 CHROMATURIA 4 0.0002
908 FLUSHING 18 0.0002
909 BLOOD PRESSURE INCREASED 27 0.0002
910 INSOMNIA 47 0.0002
911 ABDOMINAL PAIN UPPER 36 0.0002
912 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
913 DRUG INEFFECTIVE 228 0.0002
914 BLINDNESS 7 0.0002
915 HEART RATE INCREASED 17 0.0002
916 CONDITION AGGRAVATED 52 0.0002
917 DISCOMFORT 10 0.0002
918 GYNAECOMASTIA 5 0.0002
919 BLISTER 9 0.0002
920 DIZZINESS 79 0.0002
921 ABDOMINAL PAIN LOWER 4 0.0002
922 MYOCARDIAL INFARCTION 27 0.0002
923 FALL 51 0.0002
924 VISION BLURRED 21 0.0002
925 HYPERSENSITIVITY 28 0.0002
926 DISTURBANCE IN ATTENTION 8 0.0001
927 DYSGEUSIA 11 0.0001
928 INFLUENZA 16 0.0001
929 AGGRESSION 7 0.0001
930 ANGINA PECTORIS 4 0.0001
931 HYPOACUSIS 6 0.0001
932 DYSSTASIA 4 0.0001
933 BRONCHITIS 10 0.0001
934 WEIGHT INCREASED 30 0.0001
935 URTICARIA 22 0.0001
936 NEPHROLITHIASIS 6 0.0001
937 ANXIETY 37 0.0001
938 ARTHRALGIA 54 0.0001
939 CEREBROVASCULAR ACCIDENT 22 0.0001
940 TREATMENT NONCOMPLIANCE 7 0.0001
941 DRY MOUTH 10 0.0001
942 DYSPEPSIA 12 0.0001
943 LUNG NEOPLASM MALIGNANT 5 0.0001
944 INFLUENZA LIKE ILLNESS 10 0.0001
945 GAIT DISTURBANCE 23 0.0001
946 ABDOMINAL DISCOMFORT 20 0.0001
947 NASAL CONGESTION 7 0.0001
948 UNEVALUABLE EVENT 9 0.0001
949 OVERDOSE 25 0.0001
950 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
951 CONTUSION 11 0.0001
952 THERAPY INTERRUPTED 8 0.0001
953 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
954 DRUG EFFECT INCOMPLETE 4 0.0001
955 PRURITUS 42 0.0001
956 COVID-19 19 0.0001
957 FEELING HOT 6 0.0001
958 DEPRESSED MOOD 5 0.0001
959 DIABETES MELLITUS 7 0.0001
960 BLOOD GLUCOSE INCREASED 17 0.0001
961 ADVERSE DRUG REACTION 8 0.0001
962 DEPRESSION 20 0.0001
963 MEMORY IMPAIRMENT 12 0.0001
964 PROSTATE CANCER 7 0.0001
965 DYSPHONIA 5 0.0001
966 PALPITATIONS 10 0.0001
967 INJURY 6 0.0001
968 HOSPITALISATION 13 0.0001
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
970 CATARACT 5 0.0001
971 MOBILITY DECREASED 6 0.0001
972 ADVERSE EVENT 7 0.0001
973 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
974 BURNING SENSATION 5 0.0001
975 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
976 ASTHMA 7 0.0001
977 AMNESIA 4 0.0001
978 BREAST CANCER 5 0.0001
979 SWELLING 5 0.0001
980 VISUAL IMPAIRMENT 6 0.0000
981 DRY SKIN 6 0.0000
982 RHEUMATOID ARTHRITIS 5 0.0000
983 MUSCLE SPASMS 8 0.0000
984 PERIPHERAL SWELLING 6 0.0000
985 NASOPHARYNGITIS 7 0.0000
986 NO ADVERSE EVENT 6 0.0000
987 EMOTIONAL DISTRESS 4 0.0000
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
989 FEELING ABNORMAL 6 0.0000
990 INCORRECT DOSE ADMINISTERED 5 0.0000